Signaling through CD70 regulates B cell activation and IgG production - PubMed (original) (raw)
. 2004 Sep 15;173(6):3901-8.
doi: 10.4049/jimmunol.173.6.3901.
Affiliations
- PMID: 15356138
- DOI: 10.4049/jimmunol.173.6.3901
Free article
Signaling through CD70 regulates B cell activation and IgG production
Ramon Arens et al. J Immunol. 2004.
Free article
Abstract
CD70, the cellular ligand of the TNF receptor family member CD27, is expressed transiently on activated T and B cells and constitutively on a subset of B cell chronic lymphocytic leukemia and large B cell lymphomas. In the present study, we used B cells constitutively expressing CD70 to study the functional consequences of signaling through CD70. In vitro, CD70 ligation with anti-CD70 mAbs strongly supported proliferation and cell cycle entry of B cells submitogenically stimulated with either anti-CD40 mAb, LPS, or IL-4. In this process, the cell surface receptors CD25, CD44, CD69, CD95, and GL7 were up-regulated, whereas the expression of CD21, CD62L, surface IgM (sIgM), and sIgD was decreased. Addition of CD70 mAb to low dose LPS-stimulated CD70-positive B cells strongly diminished IgG secretion and enhanced production of IgM. Signaling through CD70 on B cells was dependent on the initiation of both PI3K and MEK pathways. In vivo exposure to either CD70 mAb or the CD70 counterreceptor CD27 down-regulated CD62L and sIgM on CD70-positive B cells. CD70 signaling during T cell-dependent immune responses also decreased IgG-specific Ab titers. Together, the in vitro and in vivo data demonstrate that CD70 has potent reverse signaling properties in B cells, initiating a signaling cascade that regulates expansion and differentiation.
Copyright 2004 The American Association of Immunologists, Inc.
Similar articles
- CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H, Oshima H, Takeda K, Atsuta M, Nakano H, Nakajima A, Nohara C, Yagita H, Okumura K. Akiba H, et al. J Immunol. 1999 Jun 15;162(12):7058-66. J Immunol. 1999. PMID: 10358148 - CD27/CD70 interaction directly drives B cell IgG and IgM synthesis.
Agematsu K, Kobata T, Yang FC, Nakazawa T, Fukushima K, Kitahara M, Mori T, Sugita K, Morimoto C, Komiyama A. Agematsu K, et al. Eur J Immunol. 1995 Oct;25(10):2825-9. doi: 10.1002/eji.1830251017. Eur J Immunol. 1995. PMID: 7589078 - CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.
Nagumo H, Agematsu K, Shinozaki K, Hokibara S, Ito S, Takamoto M, Nikaido T, Yasui K, Uehara Y, Yachie A, Komiyama A. Nagumo H, et al. J Immunol. 1998 Dec 15;161(12):6496-502. J Immunol. 1998. PMID: 9862673 - Plasma cell generation from B-lymphocytes via CD27/CD70 interaction.
Agematsu K, Hokibara S, Nagumo H, Shinozaki K, Yamada S, Komiyama A. Agematsu K, et al. Leuk Lymphoma. 1999 Oct;35(3-4):219-25. doi: 10.3109/10428199909145724. Leuk Lymphoma. 1999. PMID: 10706444 Review. - CD27/CD70 interactions regulate T dependent B cell differentiation.
Jacquot S. Jacquot S. Immunol Res. 2000;21(1):23-30. doi: 10.1385/IR:21:1:23. Immunol Res. 2000. PMID: 10803880 Review.
Cited by
- Targeting T Follicular Helper Cells to Control Humoral Allogeneic Immunity.
Louis K, Macedo C, Metes D. Louis K, et al. Transplantation. 2021 Nov 1;105(11):e168-e180. doi: 10.1097/TP.0000000000003776. Transplantation. 2021. PMID: 33909968 Free PMC article. Review. - Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia.
Alexandrescu DT, Wiernik PH. Alexandrescu DT, et al. Med Oncol. 2008;25(3):309-14. doi: 10.1007/s12032-007-9037-8. Epub 2008 Jan 5. Med Oncol. 2008. PMID: 18176848 - The role of TNF superfamily members in T-cell function and diseases.
Croft M. Croft M. Nat Rev Immunol. 2009 Apr;9(4):271-85. doi: 10.1038/nri2526. Nat Rev Immunol. 2009. PMID: 19319144 Free PMC article. Review. - CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus.
Munitic I, Kuka M, Allam A, Scoville JP, Ashwell JD. Munitic I, et al. J Immunol. 2013 Feb 1;190(3):1169-79. doi: 10.4049/jimmunol.1202353. Epub 2012 Dec 26. J Immunol. 2013. PMID: 23269247 Free PMC article. - Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing.
Branella GM, Spencer HT. Branella GM, et al. Cells. 2021 Dec 22;11(1):21. doi: 10.3390/cells11010021. Cells. 2021. PMID: 35011583 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous